Free Trial

Abeona Therapeutics (ABEO) Competitors

Abeona Therapeutics logo
$6.59 -0.04 (-0.60%)
Closing price 04:00 PM Eastern
Extended Trading
$6.62 +0.03 (+0.38%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ABEO vs. CALT, ELVN, GPCR, CDTX, ARDX, PRAX, PROK, COLL, AKBA, and AMPH

Should you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Calliditas Therapeutics AB (publ) (CALT), Enliven Therapeutics (ELVN), Structure Therapeutics (GPCR), Cidara Therapeutics (CDTX), Ardelyx (ARDX), Praxis Precision Medicines (PRAX), ProKidney (PROK), Collegium Pharmaceutical (COLL), Akebia Therapeutics (AKBA), and Amphastar Pharmaceuticals (AMPH). These companies are all part of the "pharmaceutical products" industry.

Abeona Therapeutics vs. Its Competitors

Abeona Therapeutics (NASDAQ:ABEO) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

In the previous week, Abeona Therapeutics had 8 more articles in the media than Calliditas Therapeutics AB (publ). MarketBeat recorded 8 mentions for Abeona Therapeutics and 0 mentions for Calliditas Therapeutics AB (publ). Abeona Therapeutics' average media sentiment score of 0.17 beat Calliditas Therapeutics AB (publ)'s score of 0.00 indicating that Abeona Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Abeona Therapeutics Neutral
Calliditas Therapeutics AB (publ) Neutral

Abeona Therapeutics has a net margin of 0.00% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. Abeona Therapeutics' return on equity of -118.82% beat Calliditas Therapeutics AB (publ)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Abeona TherapeuticsN/A -118.82% -52.48%
Calliditas Therapeutics AB (publ) -30.18%-212.04%-27.96%

Calliditas Therapeutics AB (publ) has higher revenue and earnings than Abeona Therapeutics. Calliditas Therapeutics AB (publ) is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abeona Therapeutics$3.50M96.33-$63.73M-$1.27-5.19
Calliditas Therapeutics AB (publ)$1.60B0.74-$43.96M-$1.85-21.62

Abeona Therapeutics currently has a consensus target price of $19.25, indicating a potential upside of 192.11%. Given Abeona Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe Abeona Therapeutics is more favorable than Calliditas Therapeutics AB (publ).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abeona Therapeutics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Calliditas Therapeutics AB (publ)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

80.6% of Abeona Therapeutics shares are owned by institutional investors. Comparatively, 2.8% of Calliditas Therapeutics AB (publ) shares are owned by institutional investors. 6.9% of Abeona Therapeutics shares are owned by insiders. Comparatively, 2.2% of Calliditas Therapeutics AB (publ) shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Abeona Therapeutics has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Calliditas Therapeutics AB (publ) has a beta of 1.77, meaning that its share price is 77% more volatile than the S&P 500.

Summary

Abeona Therapeutics beats Calliditas Therapeutics AB (publ) on 12 of the 16 factors compared between the two stocks.

Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABEO vs. The Competition

MetricAbeona TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$339.17M$2.96B$5.54B$9.41B
Dividend YieldN/A2.46%3.75%4.03%
P/E Ratio-5.198.2821.0120.09
Price / Sales96.33303.17433.8199.01
Price / CashN/A42.5936.1658.27
Price / Book6.527.678.125.65
Net Income-$63.73M-$55.28M$3.25B$257.91M
7 Day Performance14.81%2.50%0.97%2.09%
1 Month Performance9.83%11.70%7.36%11.13%
1 Year Performance30.75%4.89%31.31%18.40%

Abeona Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABEO
Abeona Therapeutics
3.8465 of 5 stars
$6.59
-0.6%
$19.25
+192.1%
+22.3%$339.17M$3.50M-5.1990
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
ELVN
Enliven Therapeutics
2.8636 of 5 stars
$23.00
+2.4%
$41.20
+79.1%
-1.8%$1.13BN/A-11.9850News Coverage
GPCR
Structure Therapeutics
2.9436 of 5 stars
$19.57
+2.9%
$76.17
+289.2%
-49.1%$1.12BN/A-22.49136
CDTX
Cidara Therapeutics
3.6939 of 5 stars
$55.32
+9.5%
$57.29
+3.6%
+331.6%$1.12B$1.27M-1.8890Positive News
High Trading Volume
ARDX
Ardelyx
4.1637 of 5 stars
$4.61
+2.7%
$10.89
+136.2%
-21.4%$1.10B$333.61M-20.9590Analyst Revision
PRAX
Praxis Precision Medicines
2.4592 of 5 stars
$53.60
+6.1%
$94.11
+75.6%
-0.3%$1.09B$8.55M-5.00110News Coverage
Analyst Forecast
Analyst Revision
PROK
ProKidney
3.4049 of 5 stars
$3.69
-18.7%
$5.67
+53.6%
+53.0%$1.08B$306K-6.153Analyst Forecast
Gap Up
High Trading Volume
COLL
Collegium Pharmaceutical
4.4186 of 5 stars
$32.83
+1.0%
$43.75
+33.3%
+1.0%$1.05B$631.45M26.91210Positive News
AKBA
Akebia Therapeutics
3.7148 of 5 stars
$3.97
+1.0%
$6.75
+70.0%
+175.2%$1.04B$160.18M-18.90430
AMPH
Amphastar Pharmaceuticals
4.3171 of 5 stars
$21.95
+1.3%
$32.33
+47.3%
-45.0%$1.03B$731.97M7.952,028

Related Companies and Tools


This page (NASDAQ:ABEO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners